HCPCS Code J1597

Injection, glycopyrrolate (glyrx-pf), 0.1 mg
Code effective Jul 01, 2024

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J1597 is a valid 2026 HCPCS code meaning Injection, glycopyrrolate (glyrx-pf), 0.1 mg or (Inj glycopyrrolate, glyrx-pf) for short. HCPCS J1597 has been effective since 07/01/2024 and applies to Medical care.


HCPCS Code Details - J1597

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J1597
Description

Long description:
Injection, glycopyrrolate (glyrx-pf), 0.1 mg

Short description:
Inj glycopyrrolate, glyrx-pf

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2024
Date added Added Jul 01, 2024

See also

  • HCPCS J1596 · Injection, glycopyrrolate, 0.1 mg

  • HCPCS J1598 · Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/2/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.